Anderson Glen R.'s Form 4 filing
Indaptus Therapeutics, Inc. (INDP) · filed Aug 16, 2023
- Accession no.
- 0001493152-23-029212
- Filed
- Aug 16, 2023
- Trade date
- Aug 10-14, 2023
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $216.4K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anderson Glen R.CIK 0001878961 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | Common Stock | PPurchaseAcquired | +44,354 | $1.94 | +$86,046.76 | 1,131,402 | Indirect | |
| Aug 11, 2023 | Common Stock | PPurchaseAcquired | +35,064 | $2.12 | +$74,335.68 | 1,166,466 | Indirect | |
| Aug 14, 2023 | Common Stock | PPurchaseAcquired | +23,934 | $2.34 | +$56,005.56 | 1,190,400 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.